VOYA Investment Management
LXEO icon

VOYA Investment Management’s Lexeo Therapeutics LXEO Stock Holding History

VOYA Investment Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.2K Buy
14,230
+3,525
+33% +$19.1K ﹤0.01% 2411
2026
Q1 		$61.4K Sell
10,705
-271
-2% -$1.92K ﹤0.01% 2256
2025
Q4 		$109K Buy
+10,976
New +$100K ﹤0.01% 2250

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

VOYA Investment Management's LXEO Position: Q2 2026 in Review

VOYA Investment Management increased its Lexeo Therapeutics (LXEO) stake by 33% in Q2 2026, buying an estimated $19.1K and bringing the position to 14,230 shares worth $66.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

VOYA Investment Management first reported a position in LXEO in Q4 2025 and has held it in 3 quarters since. The position peaked at $109K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • VOYA Investment Management held 14,230 shares of Lexeo Therapeutics worth $66.2K as of Q2 2026.
  • VOYA Investment Management bought 3,525 Lexeo Therapeutics shares in Q2 2026, an estimated $19.1K.
  • Lexeo Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2411 holding.
  • VOYA Investment Management first reported a position in Lexeo Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • VOYA Investment Management's Lexeo Therapeutics position peaked at $109K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.